Measuring Concerns and Needs of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within the Oncology Service
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 2,500
- Locations
- 1
- Primary Endpoint
- ESAS (Edmonton Symptom Assessment Scale)questionnaire
Study Overview
Brief Summary
In 2007, the Haifa and Western Galilee district of the CHS set out to test the feasibility of integrating complementary medicine (CM) within the CHS Oncology Service. In 2008, the CHS established the Integrative Oncology Program with the goal of addressing patient concerns and improving quality of life parameters during chemotherapy and advanced disease. The study hypothesis is that integrated medicine consultation and treatment provided within the oncology department may improve patients' concerns and well-being.
Detailed Description
In 2007, the Haifa and Western Galilee district of the CHS set out to test the feasibility of integrating complementary medicine (CM) within the CHS Oncology Service. In 2008, the CHS established the Integrative Oncology Program with the goal of addressing patient concerns and improving quality of life parameters during chemotherapy and advanced disease. The study is purposed to assess concerns, needs and perspectives of patients referred to integrative consultation during chemotherapy and/or advanced cancer; to characterize social demographic and health parameters of patients who consult or avoid integrative medicine consultation; to document complementary medicine use prior and during consultation; to assess if complementary medicine consultation and treatment improve patient's concerns and well-being; and to assess oncology provider and integrative practitioner communications issues concerning integrative care.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients with cancer diagnosis receiving chemotherapy and/or surgical treatment who are referred by their oncology provider to complementary medicine consultation
- •Age older than 18 years
Exclusion Criteria
- •Age younger than 18 years
Arms & Interventions
Complementary medicine counseling
Patients receiving chemotherapy who are referred by their oncology provider to complementary medicine consultation and treatment provided in addition to conventional supportive care
Intervention: Complementary medicine consultation and treatment (Other)
Conventional supportive care
Patients receiving conventional supportive care
Intervention: Patients receiving conventional supportive care (Other)
Outcomes
Primary Outcomes
ESAS (Edmonton Symptom Assessment Scale)questionnaire
Time Frame: 6-12 weeks(+follow-up 4 months)
Assessing the severity of 10 leading symptoms and well-being
MYCAW (Measure Yourself Concerns and Wellbeing)questionnaire
Time Frame: 6-12 weeks(+follow-up 4 months)
Assessing patients'concerns and Wellbeing as well as narrative assessment of integrative care outcomes
EORTC QLQ-C30
Time Frame: 6-12 weeks(+follow-up 4 months)
The EORTC quality of life questionnaire (QLQ) is an integrated system for assessing the health related quality of life of cancer patients. The questionnaire includes functional and symptom scales.
Secondary Outcomes
- FACIT-Sp-12 questionnaire(2-4 months)
- Attitudes concerning complementary medicine(6-12 weeks)
Investigators
Eran Ben-Arye
Integrative oncology Program, Director
Carmel Medical Center